Evidence map›Paper›PMID 34947291›Full record

ArticleMaterials (Basel, Switzerland)2021

Structural Adaptive, Self-Separating Material for Removing Ibuprofen from Waters and Sewage.

Anna Maria Skwierawska, Dominika Nowacka, Paulina Nowicka, Sandra Rosa, Katarzyna Kozłowska-Tylingo

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Anna Maria SkwierawskaDepartment of Chemistry and Technology of Functional Materials, Gdansk University of Technology, Narutowicza 11/12, 80-233 Gdansk, Poland.ORCID 0000-0003-1876-081X
Dominika NowackaDepartment of Chemistry and Technology of Functional Materials, Gdansk University of Technology, Narutowicza 11/12, 80-233 Gdansk, Poland.
Paulina NowickaDepartment of Chemistry and Technology of Functional Materials, Gdansk University of Technology, Narutowicza 11/12, 80-233 Gdansk, Poland.
Sandra RosaDepartment of Chemistry and Technology of Functional Materials, Gdansk University of Technology, Narutowicza 11/12, 80-233 Gdansk, Poland.
Katarzyna Kozłowska-TylingoDepartment of Pharmaceutical Technology and Biochemistry, Gdansk University of Technology, Narutowicza 11/12, 80-233 Gdansk, Poland.
Gdańsk University of Technology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

β-Cyclodextrin nanosponge (β-CD-M) was used for the adsorption of ibuprofen (IBU) from water and sewage. The obtained material was characterized by scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR), Brunauer-Emmett-Teller (BET), Barrett-Joyner-Halenda (BJH), Harkins and Jura t-Plot, zeta potential, thermogravimetric analysis (TGA), differential scanning calorimetry (DSC) and elementary analysis (EA). Batch adsorption experiments were employed to investigate the effects of the adsorbent dose, initial IBU concentration, contact time, electrolyte ions and humic acids, and sewage over adsorption efficiency. The experimental isotherms were show off using Langmuir, Freundlich, Hill, Halsey and Sips isotherm models and thermodynamic analysis. The fits of the results were estimated according to the Sips isotherm, with a maximum adsorption capacity of 86.21 mg g

Indexed as

adsorptionpharmaceutical pollutantssewageβ-Cyclodextrin

Identifiers

PMID34947291
PMCPMC8709425
OpenAlexW4200524742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.